The 5‐HT
3
receptor is a cation‐selective member of the pentameric ligand‐gated ion channel (pLGIC) family. It differs both structurally and functionally from the other six classes of 5‐HT receptors, which are G‐protein coupled receptors. 5‐HT
3
receptors are pentamers, and five different subunits have been identified (5‐HT3A–E). These are widely distributed, both in the nervous system and in other tissues, although the stoichiometry of most functional heteromeric receptors is still not known. 5‐HT
3
receptor activation opens a nonselective cation channel, causing depolarisation in postsynaptic cells; receptor function can be modulated by a wide range of compounds including anaesthetics, opioids and alcohols. 5‐HT
3
receptors play a major role in the vomiting reflex, regulate gut motility, secretion and peristalsis in the enteric nervous system, and are involved in information transfer in the gastrointestinal tract. Disturbances within the 5‐HT
3
receptor system may contribute to the pathogenesis of a range of neurological, gastrointestinal and immunological disorders.
Key Concepts
5‐HT
3
receptors are members of the pentameric ligand‐gated ion channel family of neurotransmitter receptors.
5‐HT
3
receptors have a bullet‐shaped structure, with extracellular, transmembrane and intracellular domains.
5‐HT
3
receptor activation opens a cation channel resulting in cell depolarisation.
5‐HT
3
receptor function can be modulated by a wide range of compounds including anaesthetics, opioids and alcohols.
5‐HT
3
receptors are involved in the function of both the central and peripheral nervous systems, including specific roles in the vomiting reflex and in the gastrointestinal tract.
Disturbances within the 5‐HT
3
receptor system may contribute to the pathogenesis of a range of neurological, gastrointestinal and immunological disorders.
5‐HT
3
receptor antagonists are effective at treating nausea, emesis and irritable bowel syndrome, and have potential in a range of other disorders.